Clinical Trials

This section is being updated. Be sure to check back soon for an updated list of enrolling and soon to be enrolling clinical trials.

PTI: A Phase I Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects with Cystic Fibrosis with any mutation.
https://clinicaltrials.gov/ct2/show/NCT02718495?term=PTI-428&rank=1

Abbvie: Long-Term Study In U.S. Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonpathy)
https://clinicaltrials.gov/show/NCT01652157

Bayer: Early Signs of Efficacy Study with Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients
https://clinicaltrials.gov/show/NCT02170025

Role of Glucagon in Glucose Control in Cystic Fibrosis Related Diabetes
https://clinicaltrials.gov/show/NCT02398383

PET Assessment of Acute of Lung Transplant Rejection
https://clinicaltrials.gov/show/NCT02204202

Redox Imbalance and the Development of CF Related Diabetes (RedoxyMeal)
https://clinicaltrials.gov/show/NCT02202876

Effect of Chronic Incretin-Based Therapy in CF (CF Related Diabetes Study)
https://www.clinicaltrials.gov/ct2/show/NCT01879228?term=nct01879228&rank=1

Blood Flow and Vascular Function in CF (Exercise, Blood Flow & Artery Function):
https://www.clinicaltrials.gov/ct2/show/NCT02057458?term=nct02057458&rank=1

Gender Disparity and Hormones in CF (Investigating Impact of Hormones in CF):
https://clinicaltrials.gov/show/NCT02036879